Menu Search
Equities

Mega Lifesciences PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MEGA-R:SET

Mega Lifesciences PCL

Actions
  • Price (THB)38.00
  • Today's Change0.25 / 0.66%
  • Shares traded2.33m
  • 1 Year change+26.67%
  • Beta--
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Institutional shareholders

1.57%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 09 Jan 20266.66m0.76%
Mellon Investments Corp.as of 09 Jan 20263.24m0.37%
BlackRock Advisors (UK) Ltd.as of 09 Jan 20261.82m0.21%
American Century Investment Management, Inc.as of 08 Jan 2026678.30k0.08%
Geode Capital Management LLCas of 30 Nov 2025283.50k0.03%
Dimensional Fund Advisors LPas of 08 Jan 2026261.60k0.03%
Robeco Institutional Asset Management BVas of 28 Nov 2025247.00k0.03%
SSgA Funds Management, Inc.as of 08 Jan 2026223.70k0.03%
Northern Trust Investments, Inc.(Investment Management)as of 09 Jan 2026130.00k0.02%
State Street Global Advisors Ltd.as of 08 Jan 2026102.70k0.01%
More ▼
Data from 30 Sep 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.